| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.13B | 26.37B | 26.22B | 25.73B | 20.16B | 10.11B |
| Gross Profit | 17.72B | 17.64B | 17.55B | 17.82B | 13.65B | 7.03B |
| EBITDA | 1.46B | 1.31B | 1.51B | 1.62B | -1.08B | 2.08B |
| Net Income | 849.72M | 504.68M | 1.08B | 938.83M | -2.02B | 1.23B |
Balance Sheet | ||||||
| Total Assets | 16.75B | 15.87B | 16.78B | 17.89B | 18.04B | 22.90B |
| Cash, Cash Equivalents and Short-Term Investments | 6.78B | 5.40B | 6.63B | 7.85B | 7.44B | 10.02B |
| Total Debt | 5.93B | 4.91B | 6.02B | 7.37B | 9.34B | 12.36B |
| Total Liabilities | 10.68B | 9.47B | 10.71B | 12.83B | 13.81B | 16.41B |
| Stockholders Equity | 6.07B | 6.40B | 6.07B | 5.06B | 4.23B | 6.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 96.12M | 33.09M | 2.21B | 519.61M | 988.40M |
| Operating Cash Flow | 0.00 | 1.37B | 769.38M | 2.78B | 1.01B | 1.89B |
| Investing Cash Flow | 0.00 | -1.29B | -688.35M | -332.41M | -193.88M | -72.89M |
| Financing Cash Flow | 0.00 | -1.31B | -1.31B | -2.04B | -3.40B | 1.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥36.54B | 56.43 | ― | ― | 20.31% | -42.76% | |
63 Neutral | ¥22.01B | 19.18 | ― | 1.20% | 2.28% | -30.11% | |
62 Neutral | ¥20.60B | 18.94 | ― | ― | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥19.93B | 171.84 | ― | 0.75% | 42.50% | 98.92% | |
50 Neutral | ¥22.38B | 45.76 | ― | 0.81% | 0.56% | -53.12% | |
49 Neutral | ¥22.75B | -268.16 | ― | 0.78% | 8.36% | -58.05% |